Biotechnology 9 January 2026

KNSA stock slides 6% after Kiniksa maps out $900–$920 million ARCALYST outlook — what’s next

Kiniksa Pharmaceuticals International, plc saw its shares drop 6.1% to $38.61 on Tuesday, following the release of updated revenue forecasts for its key drug ARCALYST. The stock briefly dipped to an intraday low of $38.27. Yahoo Finance

13 January 2026

Biotechnology·Earnings Reports·NASDAQ:KNSA·Pharmaceuticals·Stock Market

GeneDx stock drops again: WGS slides on 2026 outlook as JPM talk nears

Shares of GeneDx Holdings Corp dropped roughly 8.7% to $108.90 Tuesday afternoon, continuing their slide after the genetic testing firm revealed its 2026 revenue forecast the previous day.

13 January 2026

Biotechnology·NASDAQ:WGS·Stock Market

Structure Therapeutics stock jumps 14% as Roche-Genentech patent deal back in focus

Shares of Structure Therapeutics climbed roughly 14% on Tuesday, adding to the stock’s recent swings. The move came as investors took a fresh look at the company’s newly announced patent licensing deal with Roche’s Genentech.

13 January 2026

Biotechnology·NASDAQ:GPCR·Pharmaceuticals·Stock Market·SWX:ROG

Moderna stock jumps 12% after $1.9 billion 2025 sales view — what investors watch next

Moderna shares were up $3.97, or 11.7%, at $37.81 by late morning in New York, lifting the vaccine maker to one of the stronger movers in biotech trading.

13 January 2026

Biotechnology·Earnings·NASDAQ:MRNA

ImmunityBio stock pops on ANKTIVA lung cancer data; what IBRX investors watch next

ImmunityBio, Inc. shares rose about 6% on Tuesday after the company released new lung cancer trial results tied to its immune-boosting drug ANKTIVA. The stock was up 6.4% at $2.76, after touching $2.85 earlier in the session.

13 January 2026

Biotechnology·NASDAQ:IBRX·Stock Market

Thermo Fisher (TMO) stock slips after-hours after Nvidia lab-automation tie-up, exec shake-up

Thermo Fisher Scientific Inc shares slipped roughly 0.5% in Monday’s after-hours session, following the life-sciences tools company’s announcement of a fresh partnership with Nvidia and a shake-up in its leadership team.

13 January 2026

Biotechnology·NASDAQ:HSIC·NASDAQ:NVDA·NYSE:TMO·Stock Market

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Caris Life Sciences shares dropped roughly 8.5% to $26.08 in afternoon trading, after fluctuating between $25.35 and $29.77 earlier today.

12 January 2026

Biotechnology·NASDAQ:CAI·Stock Market

GeneDx (WGS) stock dives on 2026 guidance despite strong 2025 prelims — what to watch next

Shares of GeneDx Holdings Corp dropped roughly 14% Monday following the release of its 2026 outlook and preliminary results for 2025. The stock slipped $19.64 to trade at $115.75 in afternoon sessions.

12 January 2026

Biotechnology·Stock Market

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio Inc shares tumbled almost 18% on Monday following news of a licensing deal with Japan’s Eisai and initial sales data for its lung-cancer treatment. The stock slipped 17.7% to $6.62, after fluctuating between $8.34 and $6.32 on roughly 11.4 million shares traded.

12 January 2026

Biotechnology·Earnings Reports·NASDAQ:NUVB·Stock Market·TSX:4523

Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Shares of Johnson & Johnson climbed roughly 2.3% to $209.03 on Monday, pushing the stock near the high end of its trading range after new oncology data came out over the weekend.

12 January 2026

Biotechnology·Earnings Reports·NYSE:JNJ·Pharmaceuticals

Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results

Shares of Twist Bioscience Corp jumped roughly 8% Monday following a preliminary first-quarter revenue report that beat expectations. The synthetic DNA company’s stock climbed 7.8% to $38.07 in afternoon trading, trading between $34.51 and $39.80 earlier in the session.

12 January 2026

Biotechnology·Earnings Reports·NASDAQ:TWST

BillionToOne stock jumps after fresh 2026 revenue outlook signals faster growth

BillionToOne shares climbed roughly 7% to $92.20 during Monday’s midday session, following the company’s release of its 2026 forecast.

12 January 2026

Biotechnology·NASDAQ:BTO·Stock Market

Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna shares dropped roughly 4% on Monday following the release of updated revenue and expense forecasts ahead of a healthcare investor event. The stock fell $1.38 to $32.92, after starting the day at $34.40 and fluctuating between $35.77 and $32.81.

12 January 2026

Biotechnology·Earnings Reports·NASDAQ:MRNA·Stock Market

CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

CG Oncology shares jumped 29.3% to close at $54.20 on Friday, hitting a session high of $57.40 amid increased interest ahead of a critical bladder-cancer readout. Trading volume came in around 7.0 million shares.

12 January 2026

Biotechnology·NASDAQ:CGON·Stock Market

CRISPR Therapeutics stock (CRSP) drops into JPM week — what to watch next

CRISPR Therapeutics AG slipped 4.5% to $53.84 on Friday, putting the gene-editing stock under pressure as biotech leaders and investors gear up to converge in San Francisco this week.

12 January 2026

Biotechnology·NASDAQ:CRSP·Stock Market

Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

Regencell Bioscience Holdings Ltd shares closed Friday up 10.6% at $45.79, recovering sharply after dipping roughly 15% during the session. The Nasdaq-listed stock kicked off the day at $36.08 and swung between a low of $35.13 and a high of $50.92.

11 January 2026

Biotechnology·NASDAQ:RGC·Stock Market

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

Shares of Wave Life Sciences Ltd dropped 6.7% on Friday, ending the day at $13.84. The stock swung between a high of $15.09 and a low of $13.76 during the session.

11 January 2026

Biotechnology·NASDAQ:WVE·Stock Market

CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

CG Oncology Inc shares surged nearly 29% on Friday, closing at $54.20 after hitting a session high of $57.36. The stock gained $12.25 during the day on volume of about 7.0 million shares.

11 January 2026

Biotechnology·NASDAQ:CGON·Stock Market

Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

Schrödinger announced it will integrate Eli Lilly’s TuneLab, an AI-driven drug discovery platform, into its LiveDesign software. This move offers biotech teams direct access to Lilly’s predictive models. “LiveDesign will be a priority platform partner for TuneLab workflows,” said Pat Lorton, Schrödinger’s software chief.

10 January 2026

Artificial Intelligence·Biotechnology·NASDAQ:RVTY·NASDAQ:SDGR·NYSE:LLY

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics AG shares slid on Friday, bucking a firmer broader market, after a regulatory filing flagged a chief financial officer’s share sale under a pre-arranged trading plan.

9 January 2026

Biotechnology·NASDAQ:BEAM·NASDAQ:CRSP·NASDAQ:EDIT·NASDAQ:NTLA·NASDAQ:VRTX·Pharmaceuticals·Stock Market

Biotechnology 9 January 2026 - 13 January 2026